A consistent theme has emerged among marketing leaders across the healthcare industry over the last couple of years: there’s a daily uphill battle being waged against the rising cost of achieving that elusive milestone of long-term sustainable growth. While it’s no easy task to begin with, more and more it seems that the path to success may not be as straightforward as simply optimizing toward the lowest cost effort and calling it a win.
The modern healthcare marketer’s greatest opportunity is finding a way to harness the data at our fingertips and then allowing that data to guide intelligent decisions about where to invest, who to target, and how to define value. In doing so, we can pave the way for the development of a repeatable framework for driving growth in the places that generate the most long-term value for the organizations we serve.
That may be easier said than done in a marketing environment that’s evolving as rapidly as ours. AI-driven bidding has made campaign optimization more accessible and more commoditized. The rise of AEO is fundamentally changing the nature of search. Privacy regulations and signal loss are limiting visibility into performance, and growth expectations are still as high as ever. Budgets aren’t getting any bigger, and marketers are still expected to prove how every dollar spent contributes to meaningful outcomes.
So, if the marketing landscape is demanding more of us every day, why would we think it’s ok to keep using the same old baseline standard to measure success? Wouldn’t it be better instead to build a mechanism that allows us to get in front of all this change and make intentional decisions about where growth happens?
This is precisely where audience intelligence becomes a strategic lever. When used effectively, it allows marketers to move beyond reactive optimization and toward proactive growth. Ultimately, the goal has never been to drive incremental wins in siloed campaigns. What should be driving our decision making is the way each of those individual successes compounds in support of the broader organizational strategy.
Let’s explore tactics to shift from managing costs at the channel level to improving efficiency at the strategic level, and how smarter audience prioritization, more intentional channel roles, and a more disciplined approach to measurement are the building blocks for a truly sustainable long-term growth strategy.
Key takeaways
- Growth improves when audience value guides investment decisions, not just conversion volume or cost efficiency
- Channel performance strengthens when each tactic is assigned a clear role across the patient journey and measured accordingly
- Measurement needs to reflect long-term value, connecting acquisition to downstream revenue and patient relationships, not just immediate conversions
Jump To:
Stop segmenting. Start prioritizing.
Most healthcare organizations have a wealth of audience data. Between CRM systems, EHR data, patient surveys, and third-party sources, the sheer volume of data available is enough to overwhelm the best of us. But finding a way to make strategic sense of it is where the opportunity to elevate our growth strategy gets really exciting.
So often, our first and only plan is to use audience data to create segments and personalize messaging. Don’t get me wrong—understanding how and when to deliver the right message is an absolutely critical component of the process. But the real hidden value reveals itself when we allow audience intelligence to bring perspective. When we stop trying to make the data say what we want it to and instead allow it to lead us to smarter, macro-level marketing investment decisions, things can really get interesting.
Because the truth is, not every new patient carries the same value. Some audiences represent high-value, long-term relationships tied to strategic service lines—like a patient who enters the system through an orthopedic or cardiac care pathway. Others, like a one-and-done ED visit with no ongoing care relationship, may drive short-term volume but contribute less to overall growth. Treating them the same in your marketing approach can lead to rising acquisition costs without meaningful returns.
This is where a shift from segmentation to prioritization becomes critical.
By analyzing first- and zero-party data alongside broader market and behavioral signals, healthcare organizations can begin to identify which audiences are most likely to:
- Seek care within a defined timeframe
- Convert on higher-value services
- Generate long-term value beyond the initial encounter
That level of understanding is what starts to move marketing from reactive targeting to proactive strategy. So, instead of asking, “How do we reach this audience?” the question becomes, “Should we be investing in this audience at all?”
Analyzing the data with the goal of identifying patterns in historical results and using them to predict future behavior makes it possible to prioritize audiences not only on the critical likelihood to convert, but also the expected value to the organization.
This is where we start to view marketing acquisition costs through a different lens. When investment is focused on higher-value audiences, we can justify higher acquisition costs. For example, a health system may find that acquiring new orthopedic procedures carries a higher cost than new primary care visits. But when viewed through the lens of long-term revenue implication, orthopedics is the clear winner. Without that important context, campaign optimization efforts may unintentionally deprioritize one of the system’s most valuable growth drivers.
And the same can be true of the inverse effect, when a campaign that seems to be highly “efficient” is revealed to be driving a disproportionate allocation of budget dollars to lower value services or short-term patient relationships.
When utilized this way, audience intelligence becomes much more than a targeting tool. It becomes a true mechanism for aligning marketing investment with broader business objectives, ensuring that our resources are being spent on the audiences that are most likely to drive sustainable growth.
Strategy drives efficiency, not the other way around
Healthcare marketers have more channels at their disposal than ever before—traditional media, direct mail, paid search, social, display, programmatic, and increasingly automated solutions like Performance Max. But all that access to more channels doesn’t automatically translate to better performance.
That’s because efficiency doesn’t come from the channels themselves. It comes from how artfully they’re woven together to build a durable marketing performance mechanism.
In the same way that we just talked about using audience intelligence for more than just segmentation, channel strategy must be about more than baseline budget allocation. Of course, decisions about how much to spend in search vs social, or how to shift dollars based on real-time performance are crucial elements of a successful marketing campaign. But stepping back and asking the question, “What role does each channel play in driving growth?” will start to generate the kinds of answers that ultimately lead us where we want to go.
Different channels influence different stages of the patient journey. Treating them interchangeably, or expecting each to perform against the same acquisition cost targets, can lead to unrealistic expectations and improperly allocated long-term investment.
Our attempts to solve this challenge for clients have consistently led to an approach designed around assigning channel roles based on audience intent at different stages of the journey:
- Upper-funnel channels (e.g. display, programmatic, online video) should be evaluated on their ability to build awareness, generate qualified demand, and build high-value lead pools—not immediate conversions.
- Mid-funnel channels (e.g. paid social, retargeting) help nurture consideration, reinforcing relevance and guiding patients toward action.
- Lower-funnel channels (e.g. paid search) are designed to capture existing demand from high-intent prospects actively seeking care.
When these roles are clearly defined, budget allocation can be more intentional, and investment can be more aligned to how demand is created, nurtured, and ultimately converted.
What you measure is what the system optimizes
Now, all this reimagining of the approach to audience and channel strategy is great, but if we can’t prove any of it is working on the back end, what was the point? We’ve already discussed the idea of using audience intelligence to drive perspective about where to invest, and looking holistically at channel performance to ensure marketing dollars are spent in the right place. But how do we build a measurement apparatus to support those types of decisions? The answer, perhaps unsurprisingly, is that it’s complicated.
Most platforms are designed to optimize toward the outcomes they’re given. If success is defined purely as conversion volume, that’s what the system will pursue—regardless of whether those conversions align with broader business objectives. And as it relates to our ideal future-state, this creates a conflict. Because, again, high conversion volume is great, but if it’s misaligned with the big-picture growth plan, it can create the appearance of efficiency while masking deeper issues around the long-term patient value and service line mix challenges we’re actually trying to solve.
So, the only way to be sure of what’s working and what isn’t is to gain visibility into the metrics we truly want to measure.
By designing our reporting to lean more into value-based metrics like modeled lifetime value or downstream revenue signals, we allow marketing performance to be evaluated on cost efficiency at the campaign level and contribution to organizational goals.
This type of measurement also encourages a shift in how acquisition costs are interpreted. A higher cost to acquire a designated ‘high-value’ procedure or long-term patient relationship may contribute significantly more to our strategic growth goals than a lower cost tied to episodic or low-margin care. Framing our results reporting like this gives us the visibility to see the difference and make intelligent decisions about what to do with that information.
However, it’s worth noting that the outputs we use to make those decisions are critically dependent on the quality of the inputs feeding them. As privacy regulations have evolved and restricted our ability to track full-funnel activity, it’s become nearly impossible to paint a confident picture of what works and what doesn’t without outside help.
The reality is that healthcare organizations that invest in strengthening their data foundations, specifically around solutions that allow for visibility across the complete patient journey (not just the entry and conversion points) will be better positioned to see, understand, and act on the marketing efforts that truly drive sustainable results.
FAQs
How does audience intelligence improve marketing efficiency?
It helps identify who is most likely to drive long-term value, when they’re ready to engage, and where to focus investment, reducing wasted budget on low-impact audiences.
How should healthcare marketers decide which audiences to prioritize?
Focus on expected long-term value, not just likelihood to convert. Look at service line impact, repeat care potential, and downstream revenue to guide where investment should go
Why isn’t optimizing for the lowest CPA enough anymore?
Lower acquisition costs can mask poor outcomes if they’re tied to low-value services or one-time visits. Efficiency only matters when it supports meaningful, long-term growth.
What role should different marketing channels play in healthcare?
Each channel should align to a stage of the patient journey. Upper-funnel channels build awareness and demand, mid-funnel channels guide consideration, and lower-funnel channels capture intent.
How can marketers measure performance beyond conversions?
Incorporate value-based metrics like lifetime value, service line contribution, and downstream revenue to understand how marketing supports broader organizational goals.
Make smarter growth decisions using audience intelligence
The more I engage with folks tasked with driving growth across the healthcare industry, the more I become convinced that this is the path forward.
And here’s the good news: The organizations that are leading the charge in this arena aren’t necessarily doing anything radically different at the campaign level. They’re still using the same channels, the same platforms, and many of the same tools to get the job done.
The difference is how they’re using the tools and information at their disposal to make intelligent decisions.
They’re clearer on which audiences actually matter. They’re more intentional about the role each channel plays. And they’re measuring success in a way that reflects the outcomes they’re trying to drive—not just the activity that’s easiest to track. That alignment changes things.
It reduces the frustration of chasing efficiency that doesn’t contribute to the big picture. It creates space and justification for confident investment in high-value opportunities. It also keeps marketing tied to broader growth strategy, rather than operating as a separate function trying to optimize within its own lane—because at the end of the day, managing costs is really only one piece of the puzzle.
True long-term, sustainable growth comes from consistently making smart choices about where to focus, where to invest, and what kind of growth you’re actually trying to drive.
Looking for more healthcare insights? Explore our recent webinar with Chris Boyer, discussing what drives healthcare growth now, or let’s talk about how Amsive can help you future-proof your marketing strategy.
